English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionCenexi turnaround brings Gland Pharma close to growth revival

    Cenexi turnaround brings Gland Pharma close to growth revival

    Gland Pharma’s full year earnings are estimated to rise in FY26 after three consecutive years of declines

    R. Sree Ram
    August 08, 2025 / 08:23 IST
    Cenexi turnaround brings Gland Pharma close to growth revival

    Higher sales and improved gross margins helped Cenexi breakeven at EBITDA level in Q1 FY26

    • PRO Panorama

      Moneycontrol Pro Panorama | The big squeeze in IT jobs

      Sep 30, 2025 / 03:00 PM IST

      In Moneycontrol Pro Panorama September 30 edition: HAL and BHEL hold their ground despite competition, what should FMCG investors ...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts